\-\ Texto\\:\\ \ \(0\)\
\-\ child\\ look\\ well\\ and\\ in\\ no\\ acute\\ distress\\.\\ afebrile\\.\\ heent\\ exam\\ unremarkable\\.\\ neurological\\ examination\\ unremarkable\\.\ \(0\)\
\-\ the\\ patient\\ was\\ started\\ on\\ keppra\\ and\\ an\\ escalating\\ dose\\ will\\ be\\ utilized\\ until\\ seizures\\ are\\ adequately\\ controlled\\.\\ follow\\ up\\ mri\\ will\\ be\\ performed\\ if\\ symptoms\\ worsen\\ or\\ changes\\.\ \(0\)\
\-\ focal\\ area\\ of\\ abnornal\\ signal\\ intensity\\ in\\ the\\ right\\ posterior\\ right\\ parietal\\ occipital\\ region\\ predominantly\\ involving\\ the\\ parasagittal\\ cortex\\.\\ decreased\\ signal\\ intensity\\ on\\ t1\\ weighted\\ images\\ and\\ increase\\ signal\\ intensity\\ on\\ t2\\ weighted\\ images\\ and\\ isointense\\ in\\ flair\\ sequences\\.\\ no\\ enhancement\\ was\\ seen\\ with\\ administration\\ of\\ contrast\\.\ \(0\)\
\-\ dysembryoplastic\\ neuroepithelial\\ tumor\ \(3\)\
\-\ dysembryonic\\ neuroepithelial\\ tumor\\,\\ ganglioglioma\\,\\ oligodendroglioma\\,and\\ low\\-grade\\ astrocytoma\\.\ \(0\)\
\-\ a\\ 2\\-year\\,\\ 10\\-month\\ old\\ caucasian\\ female\\ presented\\ to\\ her\\ pediatrician\\ for\\ complaint\\ of\\ new\\ onset\\ seizures\\ times\\ four\\ weeks\\ per\\ parents\\.\\ seizures\\ occured\\ in\\ the\\ form\\ of\\ alteration\\ in\\ level\\ of\\ conciousness\\ with\\ tonic\\ eye\\ deviations\\ to\\ the\\ left\\.\\ on\\ a\\ few\\ occasions\\,\\ she\\ lost\\ body\\ tone\\ and\\ became\\ hypotonic\\ to\\ atonic\\.\\ between\\ ictal\\ episodes\\,\\ the\\ patient\\ appears\\ to\\ be\\ normal\\.\ \(0\)\
\-\ a\\ biopsy\\ of\\ the\\ brain\\ tumor\\ was\\ performed\\ in\\ this\\ case\\ to\\ elucidate\\ tumor\\ type\\ \\(\\ dysembryoplastic\\ neuroepithelial\\ tumor\\)\\.\\ resection\\ was\\ not\\ a\\ therapeutic\\ alternative\\ due\\ to\\ location\\ of\\ the\\ tumor\\ involving\\ the\\ primary\\ somatosensory\\ cortex\\.\\ management\\ of\\ seizures\\ will\\ be\\ attempted\\ with\\ keppra\\,\\ an\\ anti\\-convulsant\\.\ \(0\)\
\-\ the\\ dysembryoplastic\\ neuroepithelial\\ tumor\\ \\(dnet\\)\\ is\\ an\\ uncommon\\ lesion\\ characterized\\ by\\ a\\ heterogeneous\\ population\\ of\\ neurons\\,\\ astrocytes\\,\\ and\\ oligodendroglia\\-like\\ cells\\.\\ it\\ is\\ a\\ benign\\,\\ supratentorial\\ tumor\\ that\\ is\\ almost\\ always\\ associated\\ with\\ partial\\ complex\\ seizures\\.\\ mean\\ age\\ of\\ onset\\ of\\ symptoms\\ is\\ nine\\ years\\ and\\ range\\ between\\ 1\\-19\\ years\\ of\\ age\\.\\ the\\ prognosis\\ for\\ patients\\ with\\ dnet\\ is\\ excellent\\ with\\ 70\\-81\\%\\ of\\ patients\\ seizure\\-free\\ following\\ surgery\\.\\ surgical\\ resection\\ is\\ curative\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neuroepithelial\\:\\ 0\\.07328248871419778\ \(0\)\
\-\ dysembryoplastic\\:\\ 0\\.058823438993821336\ \(0\)\
\-\ seizures\\:\\ 0\\.058315156626410125\ \(0\)\
\-\ tumor\\:\\ 0\\.050596375913925365\ \(0\)\
\-\ keppra\\:\\ 0\\.044595294950720274\ \(0\)\
\-\ dnet\\:\\ 0\\.03396687315026521\ \(0\)\
\-\ intensity\\:\\ 0\\.029415911203612394\ \(0\)\
\-\ abnornal\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ dysembryonic\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ 10\\-month\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ somatosensory\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ anti\\-convulsant\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ oligodendroglia\\-like\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ 70\\-81\\:\\ 0\\.02798577277449682\ \(0\)\
\-\ atonic\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ ictal\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ astrocytes\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ seizure\\-free\\:\\ 0\\.02578530553462398\ \(0\)\
\-\ will\\:\\ 0\\.02546172398456326\ \(0\)\
\-\ escalating\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ 2\\-year\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ tonic\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ elucidate\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ 1\\-19\\:\\ 0\\.02449811471523298\ \(0\)\
\-\ weighted\\:\\ 0\\.023591441245347934\ \(0\)\
\-\ conciousness\\:\\ 0\\.023584838294751134\ \(0\)\
\-\ hypotonic\\:\\ 0\\.023584838294751134\ \(0\)\
\-\ cortex\\:\\ 0\\.02321563888731409\ \(0\)\
\-\ neurons\\:\\ 0\\.021808280237813286\ \(0\)\
\-\ signal\\:\\ 0\\.021457850764502656\ \(0\)\
\-\ parasagittal\\:\\ 0\\.021384371054878292\ \(0\)\
\-\ deviations\\:\\ 0\\.021384371054878292\ \(0\)\
\-\ occured\\:\\ 0\\.020675978828483977\ \(0\)\
\-\ occasions\\:\\ 0\\.020097180235487292\ \(0\)\
\-\ worsen\\:\\ 0\\.01984307640160305\ \(0\)\
\-\ involving\\:\\ 0\\.01903750643811615\ \(0\)\
\-\ pediatrician\\:\\ 0\\.018991444698127878\ \(0\)\
\-\ adequately\\:\\ 0\\.0188099894160963\ \(0\)\
\-\ nine\\:\\ 0\\.018638347443809707\ \(0\)\
\-\ alternative\\:\\ 0\\.018475511588611132\ \(0\)\
\-\ alteration\\:\\ 0\\.018320622178549444\ \(0\)\
\-\ curative\\:\\ 0\\.018172939589232325\ \(0\)\
\-\ unremarkable\\:\\ 0\\.017962326467822608\ \(0\)\
\-\ supratentorial\\:\\ 0\\.0175227985967053\ \(0\)\
\-\ between\\:\\ 0\\.017196797055392024\ \(0\)\
\-\ utilized\\:\\ 0\\.017188320769220135\ \(0\)\
\-\ onset\\:\\ 0\\.017126483974127936\ \(0\)\
\-\ resection\\:\\ 0\\.016920099400128372\ \(0\)\
\-\ mean\\:\\ 0\\.016885748769841325\ \(0\)\
\-\ be\\:\\ 0\\.01673341870912926\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.016609522176223454\ \(0\)\
\-\ age\\:\\ 0\\.01651371635266226\ \(0\)\
\-\ controlled\\:\\ 0\\.01627504434873829\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.015972472349359484\ \(0\)\
\-\ years\\:\\ 0\\.015931702457260204\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.01590112994982914\ \(0\)\
\-\ lost\\:\\ 0\\.015831355642785407\ \(0\)\
\-\ parents\\:\\ 0\\.01576308197541727\ \(0\)\
\-\ excellent\\:\\ 0\\.015503786638864038\ \(0\)\
\-\ therapeutic\\:\\ 0\\.015264080122965165\ \(0\)\
\-\ tone\\:\\ 0\\.015206878518194758\ \(0\)\
\-\ attempted\\:\\ 0\\.015150689384545868\ \(0\)\
\-\ performed\\:\\ 0\\.015127481468109962\ \(0\)\
\-\ look\\:\\ 0\\.015095477502920887\ \(0\)\
\-\ became\\:\\ 0\\.014637542236747722\ \(0\)\
\-\ dose\\:\\ 0\\.014195914292421632\ \(0\)\
\-\ population\\:\\ 0\\.01415495110246637\ \(0\)\
\-\ patients\\:\\ 0\\.01404174348803826\ \(0\)\
\-\ always\\:\\ 0\\.013957707352920318\ \(0\)\
\-\ symptoms\\:\\ 0\\.013521634773956438\ \(0\)\
\-\ characterized\\:\\ 0\\.01349577851586877\ \(0\)\
\-\ episodes\\:\\ 0\\.013398090710577487\ \(0\)\
\-\ isointense\\:\\ 0\\.013334596530556313\ \(0\)\
\-\ uncommon\\:\\ 0\\.013272347415037659\ \(0\)\
\-\ times\\:\\ 0\\.013151395522236799\ \(0\)\
\-\ heent\\:\\ 0\\.013121864116959614\ \(0\)\
\-\ almost\\:\\ 0\\.013121864116959614\ \(0\)\
\-\ caucasian\\:\\ 0\\.012950222144673024\ \(0\)\
\-\ prognosis\\:\\ 0\\.012867760283075371\ \(0\)\
\-\ predominantly\\:\\ 0\\.01270899704315581\ \(0\)\
\-\ form\\:\\ 0\\.01268329161384591\ \(0\)\
\-\ occipital\\:\\ 0\\.012657792656076817\ \(0\)\
\-\ was\\:\\ 0\\.012549555837634119\ \(0\)\
\-\ afebrile\\:\\ 0\\.012533282455590208\ \(0\)\
\-\ complaint\\:\\ 0\\.012533282455590208\ \(0\)\
\-\ flair\\:\\ 0\\.012437074996874879\ \(0\)\
\-\ few\\:\\ 0\\.01220858769647777\ \(0\)\
\-\ started\\:\\ 0\\.012100228946098537\ \(0\)\
\-\ until\\:\\ 0\\.011914042510919147\ \(0\)\
\-\ child\\:\\ 0\\.011874109868992608\ \(0\)\
\-\ per\\:\\ 0\\.011874109868992608\ \(0\)\
\-\ four\\:\\ 0\\.011776422063701325\ \(0\)\
\-\ neurological\\:\\ 0\\.011738173369999185\ \(0\)\
\-\ parietal\\:\\ 0\\.011589626825533283\ \(0\)\
\-\ distress\\:\\ 0\\.011430421163039722\ \(0\)\
\-\ increase\\:\\ 0\\.011379078752736227\ \(0\)\
\-\ eye\\:\\ 0\\.011379078752736227\ \(0\)\
\-\ sequences\\:\\ 0\\.011328553497796864\ \(0\)\
\-\ administration\\:\\ 0\\.011262413539375142\ \(0\)\
\-\ an\\:\\ 0\\.011253951088425999\ \(0\)\
\-\ range\\:\\ 0\\.010921396877086771\ \(0\)\
\-\ cells\\:\\ 0\\.010877608552857134\ \(0\)\
\-\ complex\\:\\ 0\\.010863145643219482\ \(0\)\
\-\ partial\\:\\ 0\\.010848748325234112\ \(0\)\
\-\ is\\:\\ 0\\.010710300540661442\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.010534445075153321\ \(0\)\
\-\ images\\:\\ 0\\.010408024710789549\ \(0\)\
\-\ management\\:\\ 0\\.010236607757002036\ \(0\)\
\-\ appears\\:\\ 0\\.010097551812054758\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.009975222719984144\ \(0\)\
\-\ biopsy\\:\\ 0\\.00962442298932305\ \(0\)\
\-\ location\\:\\ 0\\.009462564085409185\ \(0\)\
\-\ new\\:\\ 0\\.009453295164446218\ \(0\)\
\-\ benign\\:\\ 0\\.009362064657248257\ \(0\)\
\-\ on\\:\\ 0\\.009192266823687975\ \(0\)\
\-\ type\\:\\ 0\\.009144838820148922\ \(0\)\
\-\ body\\:\\ 0\\.00881036099266376\ \(0\)\
\-\ follow\\:\\ 0\\.008619680863322012\ \(0\)\
\-\ t1\\:\\ 0\\.008598398527696012\ \(0\)\
\-\ \\,\\:\\ 0\\.008593970333882138\ \(0\)\
\-\ area\\:\\ 0\\.008577257917886563\ \(0\)\
\-\ examination\\:\\ 0\\.008433089001506557\ \(0\)\
\-\ brain\\:\\ 0\\.008163020708897658\ \(0\)\
\-\ her\\:\\ 0\\.008156862407888684\ \(0\)\
\-\ to\\:\\ 0\\.008134630637009263\ \(0\)\
\-\ decreased\\:\\ 0\\.008065893341982728\ \(0\)\
\-\ primary\\:\\ 0\\.008036140517129194\ \(0\)\
\-\ in\\:\\ 0\\.008026613907433427\ \(0\)\
\-\ level\\:\\ 0\\.007818695325863276\ \(0\)\
\-\ changes\\:\\ 0\\.0077747554801113035\ \(0\)\
\-\ focal\\:\\ 0\\.007747598743296514\ \(0\)\
\-\ weeks\\:\\ 0\\.007699294466352852\ \(0\)\
\-\ following\\:\\ 0\\.007699294466352852\ \(0\)\
\-\ t2\\:\\ 0\\.007678059583334451\ \(0\)\
\-\ region\\:\\ 0\\.00766222611822004\ \(0\)\
\-\ she\\:\\ 0\\.007615194099854515\ \(0\)\
\-\ a\\:\\ 0\\.00755428193940193\ \(0\)\
\-\ presented\\:\\ 0\\.007394786142928283\ \(0\)\
\-\ if\\:\\ 0\\.007361090265970271\ \(0\)\
\-\ up\\:\\ 0\\.007294752860489598\ \(0\)\
\-\ enhancement\\:\\ 0\\.007271392908327098\ \(0\)\
\-\ due\\:\\ 0\\.007238975088739173\ \(0\)\
\-\ acute\\:\\ 0\\.006698029616211096\ \(0\)\
\-\ surgery\\:\\ 0\\.006587298617016746\ \(0\)\
\-\ associated\\:\\ 0\\.006401468450500641\ \(0\)\
\-\ \\%\\:\\ 0\\.006328003280463517\ \(0\)\
\-\ posterior\\:\\ 0\\.0062528207895315826\ \(0\)\
\-\ mri\\:\\ 0\\.006232621761633714\ \(0\)\
\-\ well\\:\\ 0\\.00613676493005921\ \(0\)\
\-\ it\\:\\ 0\\.006097931379469894\ \(0\)\
\-\ contrast\\:\\ 0\\.006072303767644144\ \(0\)\
\-\ exam\\:\\ 0\\.005959472825236629\ \(0\)\
\-\ case\\:\\ 0\\.005934934707515146\ \(0\)\
\-\ right\\:\\ 0\\.00572464577212963\ \(0\)\
\-\ surgical\\:\\ 0\\.005702291334131598\ \(0\)\
\-\ female\\:\\ 0\\.005577016734755027\ \(0\)\
\-\ lesion\\:\\ 0\\.005525572146033189\ \(0\)\
\-\ no\\:\\ 0\\.005463137464786045\ \(0\)\
\-\ patient\\:\\ 0\\.005438678926453257\ \(0\)\
\-\ seen\\:\\ 0\\.0053607225875164765\ \(0\)\
\-\ the\\:\\ 0\\.004827752799174234\ \(0\)\
\-\ of\\:\\ 0\\.004808093366266189\ \(0\)\
\-\ that\\:\\ 0\\.004685653106535947\ \(0\)\
\-\ for\\:\\ 0\\.004629258086620414\ \(0\)\
\-\ \\(\\:\\ 0\\.004586423658691178\ \(0\)\
\-\ and\\:\\ 0\\.004571657288437294\ \(0\)\
\-\ \\)\\:\\ 0\\.004530398045163842\ \(0\)\
\-\ by\\:\\ 0\\.004517050486491666\ \(0\)\
\-\ normal\\:\\ 0\\.004252737951108258\ \(0\)\
\-\ not\\:\\ 0\\.003920059275371223\ \(0\)\
\-\ are\\:\\ 0\\.0036980122937447673\ \(0\)\
\-\ or\\:\\ 0\\.003179437298297484\ \(0\)\
\-\ this\\:\\ 0\\.0030512292486162954\ \(0\)\
\-\ left\\:\\ 0\\.0030352548230886183\ \(0\)\
\-\ old\\:\\ 0\\.002777570148769062\ \(0\)\
\-\ \\.\\:\\ 0\\.0024793326798146606\ \(0\)\
\-\ with\\:\\ 0\\.002228650973140757\ \(0\)\
